Xanthine Oxidoreductase Is Involved in Chondrocyte Mineralization and Expressed in Osteoarthritic Damaged Cartilage
Open Access
- 9 February 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
Abstract
Pathologic calcification of cartilage consists of the formation of basic calcium phosphate (BCP) and/or calcium pyrophosphate dihydrate (CPPD) containing calcium crystals in mature hyaline or articular cartilage and is associated with aging, cartilage injury and likely plays a role in accelerating the pathology of osteoarthritis (OA). The pathways regulating joint calcification, in particular cartilage calcification, are not completely understood, but inflammation and the formation of reactive oxygen species (ROS) are contributory factors. The xanthine oxidase (XO) form of xanthine oxidoreductase (XOR), the key enzyme in xanthine and uric acid metabolism, is a major cellular source of superoxide. We hypothesized that XOR could be implicated in chondrocyte mineralization and cartilage calcification and degradation in OA. We showed both in murine primary chondrocyte and chondrogenic ATDC5 cells, that mineralization was inhibited by two different XOR inhibitors, febuxostat and allopurinol. In addition, XOR inhibition reduced the expression of the pro-mineralizing cytokine interleukin-6 (IL-6). We next generated XOR knock-out chondrocyte cell lines with undetectable XOR expression and XO activity. XOR knock-out chondrocyte cells showed decreased mineralization and reduced alkaline phosphatase (Alp) activity. To assess the precise form of XOR involved, primary chondrocytes of XOR mutant mice expressing either the XDH form (XDH ki) or the XO form (XO ki) were studied. We found that XO ki chondrocytes exhibited increased mineralization compared to XDH ki chondrocytes, and this was associated with enhanced Alp activity, ROS generation and IL-6 secretion. Finally, we found increased XOR expression in damaged vs. undamaged cartilage obtained from OA patients and XOR expression partially co-localized with areas showing pathologic calcification. Altogether, our results suggest that XOR, via its XO form, contribute to chondrocyte mineralization and pathological calcification in OA cartilage.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_173134)
This publication has 37 references indexed in Scilit:
- Chondrogenic ATDC5 cells: An optimised model for rapid and physiological matrix mineralisationInternational Journal of Molecular Medicine, 2012
- The antioxidant tempol ameliorates arterial medial calcification in uremic rats: Important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney diseaseJournal of Bone and Mineral Research, 2011
- Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activationProceedings of the National Academy of Sciences, 2011
- Calcification of articular cartilage in human osteoarthritisArthritis & Rheumatism, 2009
- Primary culture and phenotyping of murine chondrocytesNature Protocols, 2008
- Reactive oxygen species induce chondrocyte hypertrophy in endochondral ossificationThe Journal of Experimental Medicine, 2007
- Osteoarthritis development in novel experimental mouse models induced by knee joint instabilityOsteoarthritis and Cartilage, 2005
- An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extractionAnalytical Biochemistry, 2004
- Variation in the inflammatory properties of basic calcium phosphate crystals according to crystal typeArthritis & Rheumatism, 1996
- Protein- Polysaccharide Loss during Endochondral Ossification: Immunochemical EvidenceScience, 1966